Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 February 2002

Antiapoptotic effect of (-)-deprenyl in rat kidney after ischemia-reperfusion.

Eva Toronyi, János Hamar, Kálmán Magyar, Béla Szende

Med Sci Monit 2002; 8(2): BR65-68 :: ID: 420945

Abstract

BACKGROUND: Since apoptosis of renal tubular cells is the basis of thedamage caused by ischaemia-reperfusion, the antiapoptotic effect on kidney tubular epithelial cells ofthe monoamino oxidase-B (MAO-B) inhibitor (-) deprenyl (selegiline), known neuroprotective agent, withantiapoptotic properties, was studied in a rat model. MATERIAL/METHODS: Warm renal ischaemia was causedby clamping the left renal artery of rats for 30 minutes. With the start of reperfusion 0.015 mg/kg,0.15 mg/kg and 1.5 mg/kg of (-)-deprenyl was injected simultaneously into the carotid artery of the animals,respectively. Five rats served as control, in which renal artery clamping was performed, but the ratswere only treated with the solvent (physiological saline). After 6 hours of reperfusion the rats wereexsanguinated and the kidneys were histologically examined. RESULTS: Severe tubular damage characterisedby apoptosis was found in the kidneys of the untreated rats. Apoptosis was verified on the basis of morphologicalfeatures, methylgreen-pyronin staining and TUNEL reaction. (-)-Deprenyl diminished dose-dependently theapoptotic damage, 0.15 mg/kg being the most effective dose. The same dose of (-)-Deprenyl is used inthe therapy of human Parkinson's disease. CONCLUSIONS: Our findings suggest, that (-)-deprenyl mighthave an impact on decreasing renal injury also in case of human cadaveric renal transplantation.

Keywords: In Situ Nick-End Labeling, Kidney, Monoamine Oxidase Inhibitors, Rats, Wistar, Research Support, Non-U.S. Gov, selegiline

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750